Extreme heat is miserable and dangerous. It's also making us age faster
But there's another, less well-known, impact of extreme heat: It makes you age faster.
Prolonged exposure to soaring temperatures can cause a deterioration in our cells and tissues and speed up biological aging, according to a new and growing body of research.
Chronological age refers to how long a person has lived, but biological — or 'epigenetic' — age measures how well our tissues and cells function. The difference between the two explains why sometimes someone's age does not seem to match their health and vitality.
An accelerated biological age is the 'canary in the coal mine' for future risk of earlier onset of diseases such as cancer, dementia and diabetes, and early death, said Jennifer Ailshire, professor of gerontology and sociology at the University of Southern California Leonard Davis School of Gerontology.
As climate change forces people to endure increasingly severe and longer lasting heat waves, scientists say there is an urgency to better understand the ways heat is slowly and silently undermining human health at a cellular level.
How does heat accelerate aging?
Our DNA is set at birth; it is the blueprint for how the body functions and cannot be changed.
But the way DNA is expressed — the way this blueprint is carried out — can be affected by external factors that trigger chemical modifications that turn genes on or off like a light switch.
External factors affecting these switches include behaviors, such as smoking and lack of exercise, as well as environmental factors, like heat.
Heat stresses the body, making it work harder as it tries to cool down, which can damage cells. While a little bit of heat stress can be good for the body, helping increase resilience, prolonged exposure taxes the body over extended periods and can have long-term consequences.
Research on animals has pointed to strong associations between heat and accelerated aging but, until recently, there were very few studies that looked at humans.
Ailshire is one of the scientists trying to change that. She and another researcher, Eunyoung Choi, published the first population-scale research into this area in February.
They analyzed blood samples taken from a group of more than 3,600 people across the United States aged 56 and above. They used tools called 'epigenetic clocks,' which capture the way DNA is modified and provide an estimate of biological age. They then linked this to daily climate data in participants' locations in the years before the blood samples were taken.
Their results, published in February, found people who experienced at least 140 extreme heat days a year — when the heat index, a combination of temperature and humidity, was above 90 degrees Fahrenheit — aged up to 14 months faster than those in locations with less than 10 extreme heat days a year.
This link between heat and biological aging remained even when taking into account individual factors such as exercise levels and income, although the study did not look at access to air conditioning or time spent outside.
The strength of the association was significant, too. The results showed extreme heat had the same impact on aging as smoking or heavy alcohol use.
Their findings are supported by other recent research.
A 2023 study of more than 2,000 people in Germany found medium- and long-term exposure to heat was linked to accelerated biological aging. The impacts were particularly pronounced in women, who can be more vulnerable to heat as they tend to sweat less, meaning it's harder for them to cool down. People with diabetes or obesity were also more at risk, the study found.
The effects can even start before birth.
A 2024 study looked at accelerated biological aging in children in Kenya who were exposed to drought as fetuses. During pregnancy, their mothers endured heat, as well as dehydration and emotional distress.
These factors can cause stress at a cellular level that needs to be repaired, which means less energy is available for other vital functions, potentially leading to accelerated aging, the study found. Heat stress can also reduce blood flow to the uterus and placenta.
'So we see an impact on growth that includes lower birth weights and an overall harder start to life — all of which can be reflected in faster biological aging,' said Bilinda Straight, a study author and a professor at the School of Environment, Geography, and Sustainability at Western Michigan University.
What can people do?
Thiese findings do not mean that everyone living in hot places will experience accelerated aging, Ailshire said. Each person has their own risk factors and there are ways to adapt.
Access to cooling and avoiding exercise in the hottest parts of the day are important. Better nutrition, more exercise (in the cool parts of the day) and medication can also help, she added. Scientists have found drugs including metformin, prescribed for diabetes, and weight-loss medication Ozempic could slow aging.
If people can change or find ways to adapt to their heat exposure levels, it may be possible to slow or reverse the accelerated aging process, Ailshire said. 'Because that's not permanent damage; it's an indicator of the potential for permanent damage. It doesn't necessarily signify that this damage has been done.'
The area of study is very new. 'We are just at the start of understanding this process, particularly in humans,' Rongbin Xu, a research fellow at the School of Public Health and Preventive Medicine at Monash University in Australia.
But as places warm up, and heat records continue to be smashed, scientists are going to have a lot more data about the myriad ways heat affects our bodies — and who is most vulnerable.
'If we can't do anything about rising temperatures, then at a minimum, we need to be increasing awareness and finding strategies,' Ailshire said.
'There has to be a way that we can get through this.'
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
23 minutes ago
- Forbes
Your Pet's Topical Flea Treatments Harm Wildlife
If you have any itchy dog or cat, you may reach for familiar topical flea treatments like Frontline, Advantage, or PetArmor. These products promise pets fast, easy protection from fleas and ticks. Unfortunately, this convenience comes at a hidden environmental cost. Two pesticides, fipronil and imidacloprid, are typically the active ingredients in topical treatments. These same compounds were banned from agricultural use in parts of Europe and California because they are so harmful to bees and other pollinators. Yet we're still smearing these pesticides on our pets, and they are showing up in rivers and streams across the country. Flea-Killing Chemicals End Up In Waterways Topical flea treatments are designed to stay on a pet's skin and fur, but that also means they can easily wash off into household drains or outdoor water bodies. Earlier this year, a study from the University of Sussex found that dogs can continue shedding fipronil into the environment for up to 28 days after a single treatment. They further found that a single treated dog swimming in a small pond raised pesticide concentrations above safety thresholds. Pet swimming isn't the only concern. In fact, the primary route of contamination appears to be everyday activities like washing hands after applying the product, bathing pets, and laundering pet bedding. These actions send pesticide-laced water into treatment plants that are not designed to remove such compounds. One study from the California Environmental Protection Agency found fipronil in wash water from dogs treated weeks earlier. Regardless of their filtration technology, conventional wastewater treatment facilities allow these chemicals to pass through, discharging them directly into rivers, bays, and oceans. Wildlife Is Paying the Price For Pets' Fleas Fipronil and imidacloprid are extremely toxic to aquatic invertebrates. In some cases, exposure to even tiny amounts can kill freshwater shrimp and insect larvae or impair their ability to survive and reproduce. A study by the San Francisco Estuary Institute (SFEI) found fipronil in all tested sewage treatment plants at concentrations above the U.S. Environmental Protection Agency's recommended limit for aquatic ecosystems. Imidacloprid was also found at levels between 84 and 305 parts per trillion, well above the limit of 10 parts per trillion. Water and sediment samples from San Francisco Bay show pesticide levels near or above toxicity thresholds for invertebrates. According to Dr. Rebecca Sutton of SFEI, 'that's the base of our food web. So, if those critters experience impacts, it could go up and harm our fish and our wildlife.' The contamination doesn't stop with water. Another study led by the University of Sussex found fipronil in every single bird nest examined. Imidacloprid and permethrin were found in 89 percent. Birds often use pet fur to line their nests, exposing their eggs and chicks to these neurotoxins. The researchers linked this exposure to lower hatching success and higher chick mortality rates. Safer Flea Solutions Are Already Available Veterinarians increasingly recommend oral flea and tick medications, which are safer for the environment. These treatments are metabolized internally, meaning there is no pesticide residue left on pet fur to wash off into water systems. Some options include: If you must use topicals, avoid unnecessary treatments and consider seasonal use instead of year-round application. You can ask your vet about the monthly topical Revolution or the quarterly topical Bravecto. You should also keep treated pets out of natural water sources for at least 28 days after topical application. To reduce the risk of fleas in the first place, you can vacuum your home and your pet's bedding often (and empty the bag). See more tips for pet owners and veterinarians about chewable flea and tick medications from San Francisco Bay Area wastewater agencies. Flea Treatment Market Is Ripe For Innovation Though safer options exist, companies should innovate to find more solutions that protect our pets without polluting the planet. The flea and tick treatment market is valued at 9.7 billion dollars globally in 2024 and is projected to grow to 14.8 billion by 2034. For companies willing to act, this presents a strategic advantage. Brands that lead on safety, sustainability, and transparency will be well positioned as consumer awareness catches up with the science. The health of our pets and the health of our planet are linked, and both deserve better.
Yahoo
an hour ago
- Yahoo
Artemis II on track for moon flight, looking to launch as early as February 2026
The crew of 4 astronauts undertaking NASA's 2026 Artemis II mission say the moon flight is on track for its launch next year. Speaking at Kennedy Space Center in Cape Canaveral, Florida on July 30, the crew say there are possible openings for a launch in February.


Medscape
an hour ago
- Medscape
Modern Flu Vaccines Provide Equal Protection for US Seniors
TOPLINE: During the 2022-2023 influenza season, an adjuvanted quadrivalent influenza vaccine (aQIV) and high-dose (HD) QIV showed comparable effectiveness at preventing test-confirmed influenza among US adults aged 65 years or older across all hospital settings. METHODOLOGY: Researchers conducted a retrospective study using the test-negative design to evaluate the effectiveness of the aQIV vs HD-QIV in preventing laboratory-confirmed influenza among US adults aged 65 years or older during the 2022-2023 influenza season. They analyzed data of 30,911 patients (mean age, 76.7 years) from a linked administrative claims database who had an acute respiratory or febrile illness, were tested for influenza within 7 days of diagnosis, and received either aQIV or HD-QIV. Patients who tested positive for influenza (n = 2361) were classified as cases, whereas those who tested negative (n = 28,550) were considered control individuals. The analysis was adjusted for demographic and clinical covariates, including insurance type, frailty index, healthcare utilization, comorbidities, and medical conditions associated with an increased risk for influenza complications. TAKEAWAY: Overall, 31.8% and 68.2% received the aQIV and HD-QIV, respectively, with comparable rates of test-positive influenza between groups during the observation period (7.2% and 7.9%, respectively). The relative vaccine effectiveness (rVE) of aQIV vs HD-QIV showed no significant difference across all settings (adjusted rVE, -2.5%; P = .631) and emergency department/inpatient settings (adjusted rVE, 0.0%; 95% CI, -15.9% to 13.7%). During the peak season (6 November to 24 December 2022), 13.6% of aQIV and 14.4% of HD-QIV recipients tested positive for influenza, and the rVE in the sensitivity analysis was consistent with that in the main analysis. IN PRACTICE: 'These findings align with current recommendations by ACIP [Advisory Committee on Immunization Practices] and other NITAGs [National Immunization Technical Advisory Groups] that support the use of adjuvanted and high-dose influenza vaccines in this age group,' the authors wrote. SOURCE: This study was led by Mahrukh Imran, CSL Seqirus, Kirkland, Quebec, Canada. It was published online on July 11, 2025, in International Journal of Infectious Diseases. LIMITATIONS: The observational study design introduced potential biases due to variability in the use of healthcare resources and heterogeneity inherent in the US healthcare system, which could not be fully accounted for. Vaccination was not randomized, and unmeasured confounding factors might have influenced the results. The limited sample size and data privacy constraints prevented a more detailed geographic analysis. Moreover, influenza testing was performed as part of routine care than according to preset screening criteria. DISCLOSURES: This study was supported by CSL Seqirus. Three authors reported being employees of CSL Seqirus and holding stock in CSL Limited. Three other authors reported being employees of Optum, which received funding from CSL Seqirus to support this work. One author reported receiving direct financial support from the study funders. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.